Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease

V Khanijou, N Zafari, MT Coughlan… - Diabetes/Metabolism …, 2022 - Wiley Online Library
Diabetic kidney disease is expected to increase rapidly over the coming decades with rising
prevalence of diabetes worldwide. Current measures of kidney function based on …

Significance of neutrophil gelatinase-associated lipocalin as a biomarker for the diagnosis of diabetic kidney disease: a systematic review and meta-analysis

P He, M Bai, J Hu, C Dong, S Sun… - Kidney and Blood Pressure …, 2020 - karger.com
Background: Neutrophil gelatinase-associated lipocalin (NGAL) is a promising marker for
the diagnosis of diabetic kidney disease (DKD), but its utility is currently debated. This meta …

Comparisons of the relationships between multiple lipid indices and diabetic kidney disease in patients with type 2 diabetes: a cross-sectional study

C Lu, W Liu, Z Chen, L Hua, X Wang… - Frontiers in …, 2022 - frontiersin.org
Background Dyslipidemia is a well-recognized risk factor for diabetic kidney disease (DKD)
in patients with type 2 diabetes (T2D). Growing evidences have shown that compared with …

Urine NGAL as an early biomarker for diabetic kidney disease: accumulated evidence from observational studies

XY Tang, JB Zhou, FQ Luo, YP Han, W Zhao… - Renal failure, 2019 - Taylor & Francis
Objectives: Urine neutrophil gelatinase-associated lipocalin (NGAL) was found to increase
in diabetic kidney disease (DKD). However, the clinical value of urine NGAL as diagnostic …

Diagnostic accuracy of neutrophil gelatinase-associated lipocalin for predicting early diabetic nephropathy in patients with type 1 and type 2 diabetes mellitus: a …

GV Kapoula, PI Kontou, PG Bagos - The Journal of Applied …, 2019 - academic.oup.com
Background Currently, there is a lack of prediction markers for diabetic nephropathy (DN) in
patients with type 1 and type 2 diabetes mellitus (T1DM/T2DM). The aim of this systematic …

Serum adenosine deaminase levels are associated with diabetic kidney disease in type 2 diabetic patients

C Lu, W Liu, X Ge, F Xu - Endocrine Connections, 2021 - ec.bioscientifica.com
The aim of the present study was to evaluate the association between adenosine
deaminase (ADA) levels and diabetic kidney disease (DKD) in patients with type 2 diabetes …

Serum stromal cell-derived factor-1 levels are associated with diabetic kidney disease in type 2 diabetic patients

C Lu, J Ma, J Su, X Wang, W Liu, X Ge - Endocrine Journal, 2021 - jstage.jst.go.jp
The present study was designed to explore whether serum stromal cell-derived factor-1
(SDF-1) levels were associated with diabetic kidney disease (DKD). Serum SDF-1 levels …

血脂蛋白磷脂酶A2 和中性粒细胞明胶酶相关脂质运载蛋白在诊断早期糖尿病肾病中的价值

张佳思, 邹春波, 卢宇, 陈茜, 张伟亚… - 上海交通大学学报 …, 2021 - xuebao.shsmu.edu.cn
目的· 探讨血脂蛋白磷脂酶A2 (lipoprotein phospholipase A2, Lp-PLA2) 和中性粒细胞明胶酶
相关脂质运载蛋白(neutrophil gelatinase-associated lipocalin, NGAL) 在诊断早期糖尿病肾病 …

[HTML][HTML] Evaluation of renal resistive index and new biomarkers in post-hepatitis C cirrhosis patients for developing kidney injury

EAE Tony, MAA Abozaid, AA Aziz… - Journal of The …, 2024 - journals.lww.com
Background In liver cirrhosis, hemodynamic changes in splanchnic and systemic
circulations are involved. Indeed, no established laboratory markers for altered renal …

[PDF][PDF] 新生儿脑损伤生物标志物研究进展

张琦, 姜泓, 冯慧玲 - 新乡医学院学报, 2019 - jcme.org.cn
新生儿脑损伤是新生儿期常见的神经系统疾病之一, 其病因复杂, 发病机制尚未完全明确.
围生期多种病因均可导致新生儿脑损伤, 目前, 新生儿脑损伤的诊断和预后评估主要依据病史 …